Medicare drug price negotiation’s day in court
Today's D.C. Diagnosis newsletter has updates on Medicare's new power to negotiate drug prices, on Medicare Advantage, and on the latest from FDA chief Rob Califf. Read it here.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
An inside look at Medicare drug negotiation’s day in court
The post-pandemic world we live in has gotten more friendly to remote hearings and meetings — but not the U.S. District Court of Delaware. So my enterprising colleague John Wilkerson trekked up to Wilmington to give you an inside view on how a key judge viewed arguments in the first court test of the new Medicare drug price negotiation program.
What's Your Reaction?
